Press release 📈 Stocks 🌍 United States

Getlabs and Genova Diagnostics Expand In-Home Testing Services Nationwide

Getlabs integrates Genova Diagnostics' specialized testing panels into its mobile collection network, streamlining patient access to critical GI and food sensitivity diagnostics.

🕐 1 min read

2 assets impacted. Net bias: 2 Bullish, 0 Bearish, 0 Neutral. Strongest signal: Getlabs ↑ 2/10 (60% confidence).

📊 Affected Assets (2)

Getlabs
Bullish 🤖 60%
📅 Short-term 🌍 US · Explicit

Getlabs expands its mobile collection services to include Genova Diagnostics' panels, potentially increasing its service offerings and market reach.

Genova Diagnostics
Bullish 🤖 60%
📅 Short-term 🌍 US · Explicit

Genova Diagnostics partners with Getlabs to offer in-home collection for its food sensitivity and GI panels, potentially improving patient access and test utilization.

🎯 Key Takeaways

  • Getlabs now facilitates in-home collection for Genova's ALCAT, IgG food antibodies, and Celiac panels.
  • The partnership targets improved patient compliance by removing travel requirements for complex GI testing.

📝 Executive Summary

Getlabs and Genova Diagnostics have expanded their partnership to provide in-home specimen collection for specialized testing panels. The initiative covers ALCAT, food antibodies, and GI/Celiac genetic tests, aiming to remove logistical barriers for patients managing chronic gastrointestinal symptoms.

❓ FAQ

What specific tests are included in the Getlabs and Genova partnership?

The expanded service covers the ALCAT test, Food Antibodies (IgG), Celiac panels, and GI/Celiac SNP genetic testing.